Meronem I.V.

Meropenem, the active ingredient in Meronem I.V., is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, urinary tract infections, nosocomial pneumonia, septicemia, and meningitis in hospitalized patients.

GNH USA supplies Meronem I.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections.

- Complicated intra‑abdominal infections: provides effective bacterial eradication in patients with intra‑abdominal sepsis. - Complicated urinary tract infections: eliminates resistant uropathogens causing severe UTIs. - Nosocomial pneumonia: treats hospital‑acquired lung infections resistant to other agents. - Septicemia: rapidly clears bloodstream infections caused by Gram‑negative and Gram‑positive bacteria. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis.

Adverse reactions may occur with any antibiotic therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves. - Rash: erythematous skin eruption. - Elevated liver enzymes: transient increase in transaminases. - Injection site phlebitis: local irritation at infusion site.

Serious or Rare Side Effects: - Seizures: especially in patients with pre‑existing CNS disorders or renal impairment. - Clostridioides difficile colitis: severe diarrhea due to overgrowth. - Anaphylaxis: life‑threatening allergic reaction. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: acute kidney injury in susceptible individuals. - Hepatotoxicity: rare liver failure.

Use Meronem I.V. with caution and monitor patients for specific concerns.

- Renal function: adjust dose in patients with impaired renal clearance. - Hypersensitivity: avoid in individuals with known meropenem or carbapenem allergy. - Seizure risk: monitor closely in patients with CNS disorders or high doses. - Pregnancy: category unknown; prescribe only if benefits outweigh potential risks. - Breastfeeding: consider potential excretion in milk; weigh benefits against risks. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Meronem I.V. may interact with other medicines, requiring vigilance.

Major Interactions (Avoid): - Valproic acid: carbapenems reduce serum valproate levels, risking seizure breakthrough. - Probenecid: decreases renal excretion of meropenem, increasing toxicity risk. - Other nephrotoxic agents: concurrent use may exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance renal clearance, affecting drug levels. - Anticoagulants: possible alteration of INR; monitor coagulation parameters. - Other antibiotics: additive antibacterial effect may increase risk of C. difficile infection.